Majocchi's granuloma—A multicenter retrospective cohort study
JAAD International · 2023-12 · 13 · 104-111
DOI: 10.1016/j.jdin.2023.08.010 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift JAAD International, 2023-12. Verfasst von Ryan B Khodadadi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, Minnesota. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Center for Advancing Translational Sciences, Mayo Clinic.
Abstract (Originalsprache)
Background
Majocchi's granuloma (MG) is an uncommon deep fungal folliculitis predominantly caused by dermatophytes. Given the rarity of this condition, available data regarding predisposing comorbidities/risk factors, clinical characteristics, offending microbiologic pathogens, diagnostics, pathologic findings, and treatment approaches has been inferred from historical cases.
Objectives
To review our institutional experience with MG.
Methods
We retrospectively analyzed a multicenter cohort of adult patients diagnosed with MG between 1992 and 2022.
Results
We analyzed 147 patients with MG, 105 of which were male with a median age of 55.6 years. Immunosuppressant and topical corticosteroid use were common prior to development of MG. Dermatologic lesions and their sites of involvement did not differ based on the immune status of patients. Trichophyton rubrum was the most common causative pathogen of MG, in addition to other dermatophytes. Treatment duration for all prescribed agents was median 31.5 days with oral terbinafine being the most frequently utilized agent. Clinical resolution was achieved in 96.6% of cases.
Limitations
Retrospective, nonrandomized study.
Conclusions
Although rare and clinically variable in presentation, diagnosis of MG often requires histopathologic confirmation to subsequently direct prolonged treatment with systemic antifungal therapy for mycological cure.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, Minnesota.
- Department of Dermatology, Mayo Clinic, Rochester, Minnesota.
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
Förderung
- National Center for Advancing Translational Sciences
- Mayo Clinic
Zitieren
APA
Khodadadi, R. B., Yetmar, Z. A., Montagnon, C. M., Johnson, E. F., & Abu Saleh, O. M. (2023). Majocchi's granuloma—A multicenter retrospective cohort study. JAAD International, 13, 104-111. https://doi.org/10.1016/j.jdin.2023.08.010
Vancouver
Khodadadi RB, Yetmar ZA, Montagnon CM, Johnson EF, Abu Saleh OM. Majocchi's granuloma—A multicenter retrospective cohort study. JAAD International. 2023;13:104-111. doi:10.1016/j.jdin.2023.08.010
BibTeX
@article{Khodadadi2023,
author = {Khodadadi, Ryan B and Yetmar, Zachary A and Montagnon, Carmen M and Johnson, Emma F and Abu Saleh, Omar M},
title = {Majocchi's granuloma—A multicenter retrospective cohort study},
journal = {JAAD International},
year = {2023},
volume = {13},
pages = {104--111},
doi = {10.1016/j.jdin.2023.08.010}
}
EUVIMED